Long-term analysis of health-related quality of life outcomes in hereditary transthyretin amyloidosis patients treated with inotersen, demonstrating sustained benefits over extended follow-up.
Machine learning predictive model for quality of life deterioration after risankizumab withdrawal in psoriasis, identifying patient factors that inform re-treatment decisions.